Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Stability and Dividend Potential of Healthcare Stocks (GILD,BMY,DHR)
Reason why Enzo Biochem (NYSE:ENZ) surged on Friday
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) surges ahead of AACR Presentation
Vallon Pharmaceuticals Inc (VLON) stock could be just getting started
Creative Medical Technology Holdings Inc (CELZ) could double from current levels
Finance
Silvergate Capital Corp (NYSE:SI) Dramatic Surge: Exploring Potential Causes and Future…
Is the rally in Intelligent Bio Solutions Inc (INBS) stock sustainable…
Applied DNA Sciences Inc (APDN) could keep surging and here’s why
Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) Announces EMA Marketing Authorization Validation…
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:FOLD
Tag: NASDAQ:FOLD
Amicus Therapeutics, Inc. (NASDAQ: FOLD) Gets a Patent For Migalasat
Matt Wade
-
April 25, 2022
0
Amicus Therapeutics (NASDAQ: FOLD) Receives MAA Approval From EMA For AT-GAA...
Gavins Felicity
-
December 17, 2021
0
Amicus Therapeutics, Inc. (NASDAQ: FOLD) Announces that it is Preparing to...
Gavins Felicity
-
October 12, 2021
0
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Reports Topline Results Of AT-GAA In Phase...
Ward Sport
-
February 22, 2021
0
Amicus Therapeutics (NASDAQ:FOLD) Commences Rolling BLA For AT-GAA In Treatment Of...
Gavins Felicity
-
December 11, 2020
0
Amicus Therapeutics Inc. (NASDAQ:FOLD) Reports Q3 2020 Financial Results With Galafold...
Kate Hudson
-
November 13, 2020
0
Amicus Therapeutics (NASDAQ:FOLD) Announce Encouraging Preliminary AT-GTX-501 Gene Therapy Results In...
Gavins Felicity
-
October 28, 2020
0
Amicus Therapeutics (NASDAQ:FOLD) Granted PRIME Designation By European Medicines Agency For...
Ward Sport
-
September 30, 2020
0
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Posts Revenues Of $62.4 Million In Q2...
Gavins Felicity
-
August 26, 2020
0
Recent Post
Invesco QQQ Trust Series 1 (QQQ) hits all time high and...
Kate Hudson
-
June 5, 2023
0
The QQQ’s made new 12 month highs again this morning, continuing to grind higher ahead of the FED meeting next week.
Stocks In focus ahead as Wall Street grows hopeful of a...
May 26, 2023
Super Micro Computer’s Q4 Outlook ($SMCI) Boosts Investor Confidence Despite Q3...
May 3, 2023
IPOs are starting to heat up again (TRNR,GNLX,TCJH)
May 1, 2023
TOP Financial Group Limited ($TOP) surges over 600% after market hours
April 27, 2023
